Guide To Fentanyl Citrate Solubility UK In 2024 Guide To Fentanyl Citrate Solubility UK In 2024

Understanding the Solubility of Fentanyl Citrate: A Technical Overview for UK Pharmaceutical Contexts

Disclaimer: This post is meant for educational and professional details functions just. Fentanyl citrate is a Class An illegal drug in the United Kingdom under the Misuse of Drugs Act 1971. Handling and solution must only be performed by certified professionals in managed environments.

In the realm of pharmacology and scientific medication, fentanyl citrate stays one of the most potent artificial opioids readily available. Due to its high effectiveness and rapid onset of action, it is a cornerstone of pain management and anaesthesia in the UK's National Health Service (NHS) and personal healthcare sectors. However, the pharmacological effectiveness of any drug is fundamentally linked to its physicochemical properties-- specifically its solubility.

Understanding the solubility of fentanyl citrate is essential for pharmacists, researchers, and clinicians to make sure stable solutions, accurate dosing, and effective drug delivery throughout various administration routes.


What is Fentanyl Citrate?

Fentanyl citrate is the citrate salt of fentanyl, a phenylpiperidine derivative. While fentanyl base is highly lipophilic (fat-soluble), it has limited solubility in aqueous environments. By reacting the base with citric acid, moving into the salt type (fentanyl citrate), the solubility in water is considerably improved. This makes it suitable for intravenous (IV), intramuscular (IM), and transdermal applications.

In the UK, fentanyl citrate is manufactured according to the standards set by the British Pharmacopoeia (BP). It typically appears as a white, crystalline powder or as granules that are odorless.

Secret Physicochemical Properties

Residential or commercial property

Value/Description

Chemical Formula

₤ C _ 22 H _ 28 N _ 2 O \ cdot C _ 6 H _ 8 O _ 7 ₤

Molecular Weight

528.6 g/mol

CAS Number

990-73-8

pKa

Roughly 8.4 (at 25 ° C

)Appearance White crystalline powder Octanol-Water Partition Coefficient(Log P)~ 4.05(base

)Solubility Profile in Various Solvents The solubility of fentanyl citrate varies dramatically depending


on the solvent utilized and the ambient temperature. In

a pharmaceutical setting, water is the main solvent of interest for injectables, however natural solvents are often utilized during the manufacturing of transdermal patches or nasal sprays. Aqueous Solubility In the UK medical context, fentanyl citrate is most commonly encountered as a 50 mcg/mL service for injection. At room temperature(around 20 ° C to 25 ° C), fentanyl

citrate is thought about"sparingly soluble"in water. Scientific literature usually suggests a solubility limitation of roughly 25 mg/mL in water at 25 ° C, which is more than enough for standard scientific concentrations. Organic Solvent Solubility Fentanyl citrate displays different solubility in natural solvents, which is critical for developing non-aqueous drug shipment systems. Table 1: Solubility

of Fentanyl Citrate in Common Solvents at 25 ° C Solvent Solubility Category(approx.)Quantitative Estimate Water Sparingly Soluble ~ 25 mg/mL Methanol Easily Soluble > 100 mg/mL Ethanol(95 %) Soluble ~ 10-- 30 mg/mL Chloroform Soluble ~ 20-- 30 mg/mL Isopropyl Alcohol Somewhat Soluble

<10 mg/mL Aspects Influencing Solubility and Stability The solubility of fentanyl citrate is not a fixed value; it

is affected by several ecological and chemical elements that should be managed throughout compounding and

storage.

1. The Impact of pH As the

>citrate salt of a

weak base, the solubility of fentanyl is highly pH-dependent. Acidic Environments: Fentanyl citrate stays extremely soluble in acidic to neutral solutions. Many UK-licensed fentanyl injections are buffered to a pH series of

4.0 to 7.5. Alkaline Environments: If the pH of an option rises significantly above 7.5, there is a risk that the fentanyl


will shift back into its base type. Because the base

type is substantially less soluble in water, this can lead to"crashing out"or precipitation, which is exceptionally dangerous in an IV setting. 2. Temperature level Effects Like a lot of crystalline solids, the solubility of fentanyl citrate increases with temperature level. While this is handy during the industrial dissolution procedure, it presents a danger throughout storage . If Fentanyl Paper Test UK is prepared at a high temperature and then cooled (such as throughout transport in cold UK winter seasons), the solute might crystallize. 3. Presence of Other Ions(Common **Ion Effect )The presence of other citrate salts in the service can decrease the solubility of fentanyl citrate due to the typical ion impact. This is a necessary factor to consider when blending fentanyl with other medications in a syringe or infusion bag. 4. Buffer Capacity The option of buffer(e.g., sodium citrate or phosphate buffers)is

important in keeping a stable environment where the drug stays in its ionized, soluble kind. Formulating for the UK Market: British Pharmacopoeia Standards In the United Kingdom, medicinal products should stick to the British Pharmacopoeia(BP). The BP offers particular monographs for Fentanyl Citrate, making sure pureness, effectiveness, and solubility requirements are met. Secret Compounding and Formulation Rules: Clarity of Solution: The BP requires that parenteral services be clear and devoid of noticeable particles. This is achieved by ensuring the concentration remains well below the saturation point. Sterility: Given the liquid nature of the service, formulas need to be

### sterilized, typically

through autoclaving or filtration, which can affect the stability if the solubility limitations are tight. Excipients: Common additives in UK fentanyl solutions include Sodium Chloride( for isotonicity

)and Sodium Hydroxide or Hydrochloric Acid (for pH adjustment). Practical Applications of Solubility Knowledge Why does a deep understanding of fentanyl citrate's solubility matter to the health care specialist? Preventing Precipitation: Knowing that fentanyl is incompatible with highly alkaline

**solutions(like thiopentone or some bicarbonate solutions

*   **)prevents the development of precipitates that could cause embolic occasions. Optimizing Drug Delivery: In the advancement of sublingual or buccal tablets (e.g., Abstral or Effentora used in the UK), the drug must dissolve*   **rapidly in the small volume of saliva readily available. Transdermal Flux: While patches rely on the lipophilicity of the fentanyl base, the manufacture of these spots frequently involves liquifying the citrate salt in an unpredictable solvent*   **before it is fertilized into the adhesive matrix. Storage and Handling Recommendations To preserve the solubility and effectiveness of fentanyl citrate items, the following guidelines are usually

            * * *

            followed in British scientific settings: Temperature
            ----------------------------------------------------

            Control: Store at controlled room temperature level (15 ° C to 25 ° C). Prevent freezing, as this can result in irreparable precipitation in**particular solutions. Light** Protection: Fentanyl citrate is somewhat light-sensitive. Aqueous options must be kept in amber glass or nontransparent packaging. Managing Potency: Because of its high solubility and effectiveness, accidental skin contact*   **with focused options** can cause systemic absorption. Expert PPE is compulsory. Often Asked Questions(FAQ)Is fentanyl citrate more soluble than fentanyl base? Yes, substantially.
            *   **The citrate salt is developed specifically to increase aqueous solubility, making it suitable for injections. The base kind is highly lipophilic and is usually used in the internal layers of transdermal spots. Does the UK BP(British Pharmacopoeia)vary

                from the USP regarding solubility? The basic

                solubility profiles are similar as they describe the very same chemical entity. However, the precise screening techniques and the prioritized solvents for purity screening might vary

                *   **slightly between the BP** and the United States Pharmacopeia (USP). Can [Fentanyl Citrate Injection Brand Names UK](https://md.swk-web.com/s/vO3IjJzmQ) blend fentanyl citrate with saline? Yes. Fentanyl citrate is suitable with 0.9%Sodium Chloride(Normal**Saline )and 5%Dextrose. These are standard diluents used in UK health centers. What takes place if a fentanyl solution becomes cloudy? If a service of fentanyl citrate appears cloudy or includes** crystals, it should be discarded. This suggests that the drug has sped up out of the solution, either due to pH changes, temperature shifts, or contamination.

                * * *

                Why is citric acid used specifically?
                -------------------------------------

                ### Citric acid is a well-tolerated, pharmaceutical-grade natural acid. [Fentanyl Citrate Injection Brand Names UK](https://pad.geolab.space/s/VWFWR1fRE) forms a stable salt with fentanyl that uses a balance of high water solubility and compatible pH for human tissue. Fentanyl citrate is a crucial medicinal tool in the UK, but its safety and effectiveness are asserted on

                ### its chemical stability. Solubility is maybe the most vital aspect in this regard

                . By preserving an ideal pH, choosing the right solvents, and adhering to British Pharmacopoeia standards, the pharmaceutical industry guarantees that this powerful analgesic stays a dependable choice for client care.

                ### For clinicians, the takeaway is simple: constantly confirm compatibility before blending and make sure storage conditions are strictly satisfied to prevent the drug from losing its soluble state.  
                ![](https://medicstoregb.uk/wp-content/uploads/2025/09/cropped-WhatsApp-Image-2025-11-22-at-2.39.06-AM.jpeg.webp)







                ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                **

            ******

**


-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

****


Edit

Pub: 16 May 2026 13:52 UTC

Views: 1